CLVS - Clovis Oncology Inc
Previous close
0.0812
0 0%
Share volume: 0
Last Updated: Tue 20 Dec 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.08
0.00
0.00%
Summary score
31%
Profitability
25%
Dept financing
43%
Liquidity
11%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2018 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
52.14%
Return on assets
-12.11%
Return on sales
-197.29%
Return on invested capital
-49.74%
Total debt ratio
135.47%
Debt ratio change over timeo
-2.04%
Current Ratio
2.37%
Quick Ratio
2.2%
Cash Position Ratio
1.91%
Short-term ratios 30-Sep-2021 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
18.93%
Return on assets
-12.54%
Return on sales
-155.65%
Return on invested capital
-32.21%
Total debt ratio
185.06%
Debt ratio change over timeo
1.15%
Current Ratio
1.1%
Quick Ratio
1.02%
Cash Position Ratio
0.75%
Last quarter ratios 30-Sep-2022
The data are presented for the financials results of the last quarter.
Return on equity
13.4%
Return on assets
-12.76%
Return on sales
-144.26%
Return on invested capital
11.13%
Total debt ratio
220.51%
Debt ratio change over time
18.81%
Current Ratio
0.14%
Quick Ratio
0.12%
Cash Position Ratio
0.08%
Performance ratios (change over 4 years) 30-Sep-2018 - 30-Sep-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-186.62%
Return on assets
-86%
Return on sales
174.28%
Return on invested capital
-3.39%
Total debt ratio
-204.04%
Debt ratio change over time
-2.04%
Current Ratio
-5.41%
Quick Ratio
-5.1%
Cash Position Ratio
-4.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLVS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 52.14% | 0% | 0% | -98.68% |
| Return on assets | -12.11% | 0% | 0% | -10.36% |
| Return on sales | -197.29% | 0% | 0% | -4130.66% |
| Return on invested capital | -49.74% | 0% | 0% | 39.41% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 135.47% | 0% | 0% | 79.45% |
| Debt ratio change over time | -2.04% | 0% | 0% | -0.34% |
| Dept financing | 25% | 0% | 25% | 15% |
| Current Ratio | 1.1% | 0% | 0% | 10.69% |
| Quick Ratio | 1.02% | 0% | 0% | 10.69% |
| Cash Position Ratio | 0.75% | 0% | 0% | 10.53% |
| Liquididy | 22% | 0% | 0% | 75% |
| Short-term ratios | CLVS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 18.93% | 0% | 0% | -490.06% |
| Return on assets | -12.54% | 0% | 0% | -10.34% |
| Return on sales | -155.65% | 0% | 0% | -9029.8% |
| Return on invested capital | -32.21% | 0% | 0% | -85.96% |
| Profitability | 25% | 0% | 75% | 0% |
| Total debt ratio | 185.06% | 0% | 0% | 86.06% |
| Debt ratio change over time | 1.15% | 0% | 0% | -2.02% |
| Dept financing | 50% | 0% | 0% | 12% |
| Current Ratio | 1.1% | 0% | 0% | 10.69% |
| Quick Ratio | 1.02% | 0% | 0% | 10.69% |
| Cash Position Ratio | 0.75% | 0% | 0% | 10.53% |
| Liquididy | 7% | 0% | 0% | 75% |